| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2025 | ACH Accendra Health Inc/va/ | Coliseum Capital Management, LLC57 | 10% Owner | Buy | 410,000 | $7.50 | $3,073,750.00 | +1.2% | +23.3% | -59.9% | |
| Apr 10, 2025 | SNYR Synergy Chc Corp. | Ross Jack | CEO And Chairman | Buy | 14,340 | $2.74 | $39,349.60 | +0.1% | +77.1% | -67.1% | |
| Apr 9, 2025 | BTMD Biote Corp. | Guines LLC48 | 10% Owner | Buy | 48,439 | $3.21 | $155,387.68 | +0.6% | +15.7% | -57.0% | |
| Apr 9, 2025 | LFST Lifestance Health Group, Inc. | Bessler Robert67 | Director | Sell | 4,914 | $7.01 | $34,447.00 | - | -31.5% | -6.1% | |
| Apr 8, 2025 | NUTX Nutex Health, Inc. | Bates Jon Christian59 | Chief Financial Officer | Buy | 1,000 | $81.81 | $81,810.00 | +25.7% | +48.0% | +23.7% | |
| Apr 7, 2025 | ACH Accendra Health Inc/va/ | Coliseum Capital Management, LLC57 | 10% Owner | Buy | 528,356 | $8.12 | $4,291,217.84 | +1.6% | +6.5% | -68.8% | |
| Apr 7, 2025 | BTMD Biote Corp. | Guines LLC48 | 10% Owner | Buy | 74,440 | $3.19 | $237,405.51 | +0.6% | +22.8% | -54.2% | |
| Apr 2, 2025 | DGX Quest Diagnostics Inc | Davis J. E. | CEO And President | Sell | 39,191 | $168.46 | $6,602,074.29 | -1.8% | +6.8% | +17.9% | |
| Apr 2, 2025 | DGX Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | Sell | 2,555 | $170.00 | $434,350.00 | -19.5% | +6.8% | +17.9% | |
| Apr 2, 2025 | AVAH Aveanna Healthcare Holdings, Inc. | Williams Robert M Jr46 | 10% Owner | Sell | 20,324 | $5.63 | $114,424.12 | - | -11.0% | +13.5% | |
| Apr 2, 2025 | AVAH Aveanna Healthcare Holdings, Inc. | J.H. Whitney Equity Partners Vii, LLC46 | 10% Owner | Sell | 18,204 | $5.63 | $102,488.52 | - | -11.0% | +13.5% | |
| Apr 2, 2025 | AVAH Aveanna Healthcare Holdings, Inc. | Vigano Paul R46 | 10% Owner | Sell | 20,324 | $5.63 | $114,424.12 | - | -11.0% | +13.5% | |
| Apr 1, 2025 | ENSG Ensign Group, Inc | Smith Barry M51 | Director | Sell | 700 | $129.40 | $90,580.00 | -2.3% | +18.3% | +53.4% | |
| Apr 1, 2025 | ALHC Alignment Healthcare, Inc. | Joyce Christopher J46 | Chief Legal And Admin. Officer | Sell | 25,000 | $18.47 | $461,632.50 | -5.7% | -22.6% | -1.3% | |
| Mar 31, 2025 | BTMD Biote Corp. | Guines LLC48 | 10% Owner | Buy | 106,000 | $3.32 | $351,920.00 | +2.7% | +20.7% | -59.5% | |
| Mar 31, 2025 | CHE Chemed Corp | McNamara Kevin J57 | President And CEO | Sell | 1,000 | $615.33 | $615,330.00 | -1.0% | -20.9% | -38.6% | |
| Mar 28, 2025 | LH Labcorp Holdings Inc. | Summy Amy B.47 | EVP, Chief Marketing Officer | Sell | 758 | $231.67 | $175,605.86 | -12.5% | +11.7% | +14.9% | |
| Mar 28, 2025 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, Pres Diagnostics &COO | Sell | 2,635 | $231.67 | $610,450.45 | -34.7% | +11.7% | +14.9% | |
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Scavo Robert L.45 | Chief Information Officer | Sell | 2,864 | $17.89 | $51,236.96 | -0.4% | -24.4% | -8.3% | |
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Maroney Dawn Christine56 | President | Sell | 11,152 | $17.89 | $199,509.28 | -0.5% | -24.4% | -8.3% | |
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Freeman Robert Thomas58 | Chief Financial Officer | Sell | 6,744 | $17.89 | $120,650.16 | -0.5% | -24.4% | -8.3% | |
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Kao John E69 | Chief Executive Officer | Sell | 34,430 | $17.89 | $615,952.70 | -0.7% | -24.4% | -8.3% | |
| Mar 27, 2025 | ALHC Alignment Healthcare, Inc. | Kardes Hakan | Chief Experience Officer | Sell | 7,225 | $17.89 | $129,255.25 | -1.1% | -24.4% | -8.3% | |
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Pacala Mark L | Director | Buy | 90,562 | $1.04 | $94,338.44 | +67.4% | +94.2% | +156.2% | |
| Mar 26, 2025 | TOI Oncology Institute, Inc. | Virnich Daniel | Chief Executive Officer | Buy | 22,640 | $1.04 | $23,584.09 | +3.2% | +94.2% | +156.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.